• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直肠癌术前放化疗与化疗的组织学差异:一项临床病理研究

Histological differences between preoperative chemoradiotherapy and chemotherapy for rectal cancer: a clinicopathological study.

作者信息

Sakuyama Naoki, Kojima Motohiro, Kawano Shingo, Akimoto Tetsuo, Saito Norio, Ito Masaaki, Ochiai Atsushi

机构信息

Division of Colorectal Surgery, National Cancer Center Hospital East, Chiba, Japan.

Juntendo University Graduate School of Medicine, Advanced Clinical Research of Cancer, Tokyo, Japan.

出版信息

Pathol Int. 2016 May;66(5):273-80. doi: 10.1111/pin.12409.

DOI:10.1111/pin.12409
PMID:27112135
Abstract

Pathological studies on the different histological effects between neoadjuvant chemotherapy (NAC) and preoperative chemoradiation therapy (preoperative CRT) have not been performed. The purpose of this study is to elucidate the histological differences in tissue received from NAC and preoperative CRT for rectal cancer to evaluate whether a pathological assessment method used after CRT can be applied for NAC. One hundred and thirty-eight patients were enrolled in this study; 88 patients underwent their operations after preoperative CRT or NAC, and 50 patients underwent surgery only. Residual tumor area was measured using morphometry software and we compared the stromal component of myofibroblasts, immune cells, and vasculature to elucidate the difference of therapeutic effect between them. The grade of reduction after preoperative CRT was more prominent than that seen in NAC. Also, ypT downstaging was more prominent in preoperative CRT than in NAC, and ypN downstaging was more frequent in NAC than in preoperative CRT. Preoperative CRT showed more marked myofibroblasts and fewer immune cells than did NAC, which indicates different effects on the cancer microenvironment. Our histological results suggest different effects between NAC and preoperative CRT on tumor tissue. The best assessment method available for a variable therapeutic protocol should be further investigated.

摘要

尚未对新辅助化疗(NAC)和术前放化疗(术前CRT)之间不同的组织学效应进行病理学研究。本研究的目的是阐明直肠癌患者接受NAC和术前CRT后组织的组织学差异,以评估CRT后使用的病理评估方法是否可应用于NAC。本研究共纳入138例患者;88例患者在术前CRT或NAC后接受手术,50例患者仅接受手术。使用形态测量软件测量残余肿瘤面积,并比较肌成纤维细胞、免疫细胞和脉管系统的基质成分,以阐明它们之间治疗效果的差异。术前CRT后的缩小程度比NAC更显著。此外,术前CRT的ypT降期比NAC更显著,而NAC的ypN降期比术前CRT更频繁。与NAC相比,术前CRT显示出更多的肌成纤维细胞和更少的免疫细胞,这表明对癌症微环境的影响不同。我们的组织学结果表明,NAC和术前CRT对肿瘤组织的影响不同。对于可变的治疗方案,应进一步研究可用的最佳评估方法。

相似文献

1
Histological differences between preoperative chemoradiotherapy and chemotherapy for rectal cancer: a clinicopathological study.直肠癌术前放化疗与化疗的组织学差异:一项临床病理研究
Pathol Int. 2016 May;66(5):273-80. doi: 10.1111/pin.12409.
2
Area of residual tumor is a robust prognostic marker for patients with rectal cancer undergoing preoperative therapy.残留肿瘤面积是接受术前治疗的直肠癌患者的一个可靠预后标志物。
Cancer Sci. 2018 Mar;109(3):871-878. doi: 10.1111/cas.13521.
3
Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.扩散加权磁共振成像和磁共振容积测量法——用于评估局部晚期直肠癌患者术前放化疗后的肿瘤反应。
Magn Reson Imaging. 2015 Feb;33(2):201-12. doi: 10.1016/j.mri.2014.08.041. Epub 2014 Nov 13.
4
Reevaluation of Preoperative Chemoradiotherapy for Clinical T3 Lower Rectal Cancer: A Multicenter Collaborative Retrospective Clinical Study.临床T3期低位直肠癌术前放化疗的再评估:一项多中心协作回顾性临床研究
Anticancer Res. 2019 Jun;39(6):3047-3052. doi: 10.21873/anticanres.13438.
5
Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer.术前放化疗后肿瘤体积减少率作为局部晚期直肠癌的预后因素。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e193-9. doi: 10.1016/j.ijrobp.2011.03.022. Epub 2011 May 24.
6
Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.局部晚期直肠癌术前放化疗后的最佳手术时间
Ann Surg. 2008 Aug;248(2):243-51. doi: 10.1097/SLA.0b013e31817fc2a0.
7
Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations.低位直肠癌的术前放化疗。对降期及保肛手术的影响。
Hepatogastroenterology. 2004 Nov-Dec;51(60):1703-7.
8
Area of residual tumor beyond the muscular layer is a useful predictor of outcome in rectal cancer patients who receive preoperative chemoradiotherapy.肿瘤残留区域超出肌层是接受术前放化疗的直肠癌患者预后的有用预测指标。
Pathol Int. 2009 Dec;59(12):857-62. doi: 10.1111/j.1440-1827.2009.02464.x.
9
Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.磁共振成像定义的局部进展期直肠癌的同期放化疗后手术和辅助卡培他滨加奥沙利铂(CAPOX)与诱导 CAPOX 后同期放化疗和手术的随机 II 期研究:Grupo cancer de recto 3 研究。
J Clin Oncol. 2010 Feb 10;28(5):859-65. doi: 10.1200/JCO.2009.25.8541. Epub 2010 Jan 11.
10
Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.使用 18FDG-PET/CT 预测局部晚期直肠癌新辅助放化疗的病理反应。
Ann Surg Oncol. 2012 Jul;19(7):2178-85. doi: 10.1245/s10434-012-2248-z. Epub 2012 Mar 7.

引用本文的文献

1
Neoadjuvant chemotherapy versus long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis of 5,168 cases.新辅助化疗与长程新辅助放化疗治疗局部晚期直肠癌的比较:一项对5168例病例的系统评价和荟萃分析
Front Oncol. 2025 Jun 26;15:1542885. doi: 10.3389/fonc.2025.1542885. eCollection 2025.
2
Short- and long-term outcomes of neoadjuvant chemotherapy compared with neoadjuvant chemoradiotherapy for locally advanced rectal cancer: an updated meta-analysis.新辅助化疗与新辅助放化疗治疗局部晚期直肠癌的短期和长期结局比较:一项更新的荟萃分析
BMC Gastroenterol. 2025 Feb 17;25(1):87. doi: 10.1186/s12876-025-03667-8.
3
Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer - possible implications for immunotherapy.
KRAS 和 BRAF 突变对结直肠癌免疫细胞浸润的相反作用 - 对免疫治疗的可能影响。
Br J Cancer. 2024 Jan;130(1):143-150. doi: 10.1038/s41416-023-02483-9. Epub 2023 Dec 1.
4
Neoadjuvant chemotherapy without radiation as a potential alternative treatment for locally advanced rectal cancer: A meta-analysis.新辅助化疗联合放疗作为局部晚期直肠癌潜在替代治疗方案的Meta分析
World J Gastrointest Oncol. 2021 Sep 15;13(9):1196-1209. doi: 10.4251/wjgo.v13.i9.1196.
5
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer.局部晚期直肠癌新辅助化疗与新辅助放化疗的Meta分析。
World J Surg Oncol. 2021 May 5;19(1):141. doi: 10.1186/s12957-021-02251-0.
6
Endoscopic and MRI response evaluation following neoadjuvant treatment for rectal cancer: a pictorial review with matched MRI, endoscopic, and pathologic examples.直肠癌新辅助治疗后内镜和 MRI 反应评估:伴有匹配 MRI、内镜和病理示例的影像学综述。
Abdom Radiol (NY). 2021 May;46(5):1783-1804. doi: 10.1007/s00261-020-02827-6. Epub 2020 Oct 28.
7
Patterns of recurrence in patients with curative resected rectal cancer according to different chemoradiotherapy strategies: Does preoperative chemoradiotherapy lower the risk of peritoneal recurrence?根据不同放化疗策略,根治性切除直肠癌患者的复发模式:术前放化疗能否降低腹膜复发风险?
Oncol Lett. 2020 Nov;20(5):242. doi: 10.3892/ol.2020.12105. Epub 2020 Sep 15.
8
Clinicopathologic determinants of pathologic treatment response in neoadjuvant treated rectal adenocarcinoma.新辅助治疗直肠腺癌的病理治疗反应的临床病理决定因素。
Ann Diagn Pathol. 2020 Apr;45:151452. doi: 10.1016/j.anndiagpath.2019.151452. Epub 2019 Dec 14.
9
The Prognostic Importance of CD20 B lymphocytes in Colorectal Cancer and the Relation to Other Immune Cell subsets.结直肠癌中 CD20 B 淋巴细胞的预后意义及其与其他免疫细胞亚群的关系。
Sci Rep. 2019 Dec 27;9(1):19997. doi: 10.1038/s41598-019-56441-8.
10
Ki67 expression and localization of T cells after neoadjuvant therapies as reliable predictive markers in rectal cancer.新辅助治疗后 Ki67 表达和 T 细胞定位可作为直肠癌可靠的预测标志物。
Cancer Sci. 2020 Jan;111(1):23-35. doi: 10.1111/cas.14223. Epub 2019 Dec 18.